Skip to content

Clinical trials

Phase 3 Squamous Cell Carcinoma of Head and Neck trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 3 Country / region: Germany Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20051
20101
20141
20152
20161
20171
20204
20211
20244
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting6
Terminated4
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
European Organisation for Research and Treatment of Cancer - EORTC2
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
Merus B.V.2
AVEO Pharmaceuticals, Inc.1
Bristol-Myers Squibb1
Corbus Pharmaceuticals Inc.1
Dana-Farber Cancer Institute1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck22
Head and Neck Neoplasms9
Carcinoma, Squamous Cell2
Laryngeal Diseases2
Neoplasm Metastasis2
Recurrence2
Carcinoma1
Oropharyngeal Neoplasms1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.